Immediate Impact

9 standout
Sub-graph 1 of 4

Citing Papers

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial
2024 Standout
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
2023 Standout
1 intermediate paper

Works of Leroy Griffing being referenced

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon
2021

Author Peers

Author Last Decade Papers Cites
Leroy Griffing 37 15 6 25 5 52
R. Garn Mabey 26 6 16 10 165
D. M. Wright 44 91 13 22 2 176
Panagiota Pagoni 10 19 16 23 7 183
Vandana Girotra 23 30 27 5 66
Andrea Caramma 34 4 4 24 4 59
Cynthia Huffman 63 8 1 29 6 176
Kathy Moser Sivils 6 15 3 11 3 63
Teresa Montojo 52 3 2 55 6 72
Matteo Benini 30 8 30 5 42
Olivier Dereeper 20 12 11 4 46

All Works

Loading papers...

Rankless by CCL
2026